Author:
Chiang Chen-Yuan,Hinderaker Sven Gudmund,Lin Hsien-Ho,Enarson Donald A.
Reference33 articles.
1. Andersen, P., Munk, M. E., Pollock, J. M., & Doherty, T. M. (2000). Specific immune-based diagnosis of tuberculosis. Lancet, 356(9235), 1099–1104.
2. Andersen, P., Doherty, T. M., Pai, M., & Weldingh, K. (2007). The prognosis of latent tuberculosis: Can disease be predicted? Trends in Molecular Medicine, 13, 175–182.
3. Badri, M., Wilson, D., & Wood, R. (2002). Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: A cohort study. Lancet, 359, 2059–2064.
4. Barry, C. E., III, Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., et al. (2009). The spectrum of latent tuberculosis: Rethinking the biology and intervention strategies. Nature Reviews Microbiology, 7, 845–855.
5. Cauthen, G. M., Pio, A., & Ten Dam, H. G. (1988). Annual risk of tuberculous infection (World Health Organization Document WHO/TB/88.154). pp. 1–34.